EUVIMEDEUVIMED entdecken
Crossref

Treatment Outcomes of Stereotactic Body Radiotherapy for Ground Glass Opacity Nodules and Solid Lung Cancer

Yasushi Hamamoto, Kenji Makita, Hiromitsu Kanzaki, Kei Nagasaki, Hiroshi Suehisa, Hisayuki Shigematsu, Tsuyoshi Ueno, Daijiro Harada, Takashi Ninomiya, Toshiyuki Kozuki, Motohiro Yamashita

Asia-Pacific Journal of Clinical Oncology · 2026-04 · 22 (2) · 207-214

DOI: 10.1111/ajco.14194 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, online erschienen am 30.05.2025. Verfasst von Yasushi Hamamoto und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan. Hauptthemen laut MEDLINE: Radiosurgery, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Disease control outcomes of ground glass opacity nodules (GGNs) treated with stereotactic body radiotherapy (SBRT) were evaluated with comparing to solid lung cancer. Material and Methods Patients who received SBRT for primary lung cancer with maximum tumor diameter of 5 cm or smaller between July 2006 and February 2012 were retrospectively reviewed.

Results

A total of 169 primary lung cancer (GGNs, 40; solid lung cancer, 129) in 151 patients (age, 55–92; median, 79) were treated with SBRT of 48–62.5 Gy in 4–5 fractions (mean 50.3 Gy). Median follow‐up time was 52 months (3–180 months). For GGNs and solid lung cancer, 5‐year local failure free rates (LFF) were 94% and 74% ( p = 0.0223), 5‐year regional failure free rates (RFF) were 95% and 79% ( p = 0.0293), 5‐year distant failure free rates (DFF) were 86% and 77% ( p = 0.0803), and 5‐year overall survival rates (OS) were 73% and 40% ( p < 0.0001). In multivariable analysis, tumor appearance of solid lung cancer was the significant unfavorable factor for LFF, RFF, and OS. When GGNs were classified into two groups according to consolidation to maximum tumor diameter ratio (CTR), 5‐year LFF, RFF, and DFF were 100%, 100%, and 93% for GGNs with CTR < 0.5, and 71%, 78%, and 62% for GGNs with CTR ≥ 0.5.

Conclusions

LFF and RFF after SBRT were significantly better in GGNs compared to solid lung cancer. However, local, regional, and distant failure were not uncommon in GGNs with CTR ≥ 0.5, as were solid lung cancer. Disease control outcomes of SBRT was favorable in GGNs with CTR < 0.5.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiosurgeryLung NeoplasmsHumansMaleFemaleAgedMiddle AgedRetrospective StudiesAged, 80 and overTreatment Outcome

Stichwörter der Autor:innen

ground glass opacity nodulelung cancerstereotactic body radiotherapytreatment outcomes

Autor:innen und Institutionen

  • Department of Radiation Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan.
  • Department of Thoracic Surgery, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan.
  • Department of Thoracic Oncology and Medicine, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan.

Zitieren

APA

Hamamoto, Y., Makita, K., Kanzaki, H., Nagasaki, K., Suehisa, H., Shigematsu, H., Ueno, T., Harada, D., Ninomiya, T., Kozuki, T., & Yamashita, M. (2026). Treatment Outcomes of Stereotactic Body Radiotherapy for Ground Glass Opacity Nodules and Solid Lung Cancer. Asia-Pacific Journal of Clinical Oncology, 22(2), 207-214. https://doi.org/10.1111/ajco.14194

Vancouver

Hamamoto Y, Makita K, Kanzaki H, Nagasaki K, Suehisa H, Shigematsu H, et al. Treatment Outcomes of Stereotactic Body Radiotherapy for Ground Glass Opacity Nodules and Solid Lung Cancer. Asia-Pacific Journal of Clinical Oncology. 2026;22(2):207-214. doi:10.1111/ajco.14194

BibTeX
@article{Hamamoto2026,
  author = {Hamamoto, Yasushi and Makita, Kenji and Kanzaki, Hiromitsu and Nagasaki, Kei and Suehisa, Hiroshi and Shigematsu, Hisayuki and Ueno, Tsuyoshi and Harada, Daijiro and Ninomiya, Takashi and Kozuki, Toshiyuki and Yamashita, Motohiro},
  title = {Treatment Outcomes of Stereotactic Body Radiotherapy for Ground Glass Opacity Nodules and Solid Lung Cancer},
  journal = {Asia-Pacific Journal of Clinical Oncology},
  year = {2026},
  volume = {22},
  number = {2},
  pages = {207--214},
  doi = {10.1111/ajco.14194}
}
Kostenlos starten →